D. Abrahami

First name
D.
Last name
Abrahami
Abrahami, D., Tesfaye, H., Yin, H., Vine, S., Hicks, B., H. Y. Yu, O., et al. (2022). Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1174
Douros, A., Abrahami, D., Yin, H., H. Y. Yu, O., Renoux, C., Hudson, M., & Azoulay, L. (2018). Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000891
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., et al. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Abrahami, D., Yin, H., H. Y. Yu, O., Pollak, M. N., & Azoulay, L. (2018). Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000793
Abrahami, D., Douros, A., Yin, H., H. Y. Yu, O., Renoux, C., Bitton, A., & Azoulay, L. (2018). Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k872
Abrahami, D., Douros, A., Yin, H., H. Y. Yu, O., & Azoulay, L. (2019). Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0849
Abrahami, D., McDonald, E. G., Schnitzer, M., & Azoulay, L. (2020). Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-041529
Abrahami, D., Renoux, C., Yin, H., Fournier, J. P., & Azoulay, L. (2020). The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation. Thromb Haemost. http://doi.org/10.1055/s-0040-1714213
Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., & Azoulay, L. (2021). Proton pump inhibitors and risk of colorectal cancer. Gut. http://doi.org/10.1136/gutjnl-2021-325096
Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., & Azoulay, L. (2021). Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. http://doi.org/10.1136/gutjnl-2021-325097